BE study designs [Design Issues]

posted by shiv – 2006-01-25 07:46 (7028 d 10:43 ago) – Posting: # 61
Views: 27,804

Hello Helmut

I am shiv. I quite impressed for your inputs on study design. I would like to update on ANVISA approval process.

Initially ANVISA approval is for the facility and after approval only we have to conduct the studies. Please update us the current process is it pre approval or post study approval.

Regards
shiv prasad

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
14 visitors (0 registered, 14 guests [including 2 identified bots]).
Forum time: 19:29 CEST (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5